KINGSLEY ALFRED D

13D Group-10% Owner at Lineage Cell Therapeutics, Inc. · on record since Feb 14, 2006
Chairman at Lineage Cell Therapeutics, Inc. · on record since Jul 6, 2011
10% owner at Lineage Cell Therapeutics, Inc. · on record since Feb 14, 2008
Director at Lineage Cell Therapeutics, Inc. · on record since Aug 24, 2009
Director at Asterias Biotherapeutics, Inc. · on record since Sep 30, 2013
Director at Insight Molecular Diagnostics Inc. · on record since Dec 31, 2015

Insider trading activity of KINGSLEY ALFRED D

Transactions on record: 147; since Oct 10, 2003

Open-market buys: 20; $172.3K

Open-market sells: 12; $4.8M

Companies traded: 3; last filing Jul 3, 2023

Figures computed from official regulatory filings — .

Companies where KINGSLEY ALFRED D has traded

Lineage Cell Therapeutics, Inc.111 tx · $14.3M · Jul 3, 2023
Insight Molecular Diagnostics Inc.31 tx · $373.6K · Jun 27, 2023
Asterias Biotherapeutics, Inc.5 tx · $33.3K · Jun 10, 2016

Track record of KINGSLEY ALFRED D

Statistical track record

Free account

Open-market buys: 21

Last buy: Jun 14, 2023

Win rates, median returns and the proven-insider analysis come with a free account.

Transaction history of KINGSLEY ALFRED D

Co-insiders of KINGSLEY ALFRED D

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Lineage Cell Therapeutics, Inc.Listing on record	Jul 3, 2023	AwardD (derivative)	50,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Insight Molecular Diagnostics Inc.Listing unverified	Jun 27, 2023	Award	20,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Insight Molecular Diagnostics Inc.Listing unverified	Jun 27, 2023	AwardD (derivative)	90,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Insight Molecular Diagnostics Inc.Listing unverified	Jun 15, 2023	Buy	30,000	0.21 USD	$6.3K	conv 44Cluster	SEC
Lineage Cell Therapeutics, Inc.Listing on record	Feb 14, 2023	Gift	-25,000	—	n/a (No price was disclosed in the filing)		SEC
Insight Molecular Diagnostics Inc.Listing unverified	Dec 27, 2022	Buy	25,000	0.29 USD	$7.2K	conv 15	SEC
Insight Molecular Diagnostics Inc.Listing unverified	Aug 17, 2022	Buy	5,000	0.97 USD	$4.9K	conv 36ClusterFirst in 12mo	SEC
Insight Molecular Diagnostics Inc.Listing unverified	Aug 17, 2022	Award	10,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Insight Molecular Diagnostics Inc.Listing unverified	Aug 17, 2022	Buy	5,000	0.97 USD	$4.9K	conv 36ClusterFirst in 12mo	SEC
Insight Molecular Diagnostics Inc.Listing unverified	Aug 17, 2022	AwardD (derivative)	45,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Insight Molecular Diagnostics Inc.Listing unverified	Jul 19, 2022	ExerciseD (derivative)	-10,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Insight Molecular Diagnostics Inc.Listing unverified	Jul 19, 2022	Exercise	10,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Lineage Cell Therapeutics, Inc.Listing on record	Jul 6, 2022	AwardD (derivative)	50,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Lineage Cell Therapeutics, Inc.Listing on record	Feb 11, 2022	Gift	-14,700	—	n/a (No price was disclosed in the filing)		SEC
Lineage Cell Therapeutics, Inc.Listing on record	Jul 1, 2021	AwardD (derivative)	80,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Insight Molecular Diagnostics Inc.Listing unverified	Jun 28, 2021	AwardD (derivative)	45,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Insight Molecular Diagnostics Inc.Listing unverified	Jun 28, 2021	AwardD (derivative)	10,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Lineage Cell Therapeutics, Inc.Listing on record	Jun 23, 2021	Exercise	61,800	2.20 USD	$136K	Unusual size	SEC
Lineage Cell Therapeutics, Inc.Listing on record	Jun 23, 2021	ExerciseD (derivative)	-61,800	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Lineage Cell Therapeutics, Inc.Listing on record	Feb 12, 2021	Gift	-17,500	—	n/a (No price was disclosed in the filing)		SEC
Insight Molecular Diagnostics Inc.Listing unverified	Dec 28, 2020	Exercise	1,237	1.34 USD	$1.7K		SEC
Insight Molecular Diagnostics Inc.Listing unverified	Dec 28, 2020	ExerciseD (derivative)	65,271	1.34 USD	$87.5K		SEC
Insight Molecular Diagnostics Inc.Listing unverified	Dec 28, 2020	ExerciseD (derivative)	1,237	1.34 USD	$1.7K		SEC
Insight Molecular Diagnostics Inc.Listing unverified	Dec 28, 2020	Sell	-900	2.55 USD	$2.3K		SEC
Insight Molecular Diagnostics Inc.Listing unverified	Dec 28, 2020	Exercise	65,271	1.34 USD	$87.5K		SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Lineage Cell Therapeutics, Inc.Listing on record	Jul 3, 2023	AwardD (derivative)	50,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Insight Molecular Diagnostics Inc.Listing unverified	Jun 27, 2023	Award	20,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Insight Molecular Diagnostics Inc.Listing unverified	Jun 27, 2023	AwardD (derivative)	90,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Insight Molecular Diagnostics Inc.Listing unverified	Jun 15, 2023	Buy	30,000	0.21 USD	$6.3K	conv 44Cluster	SEC
Lineage Cell Therapeutics, Inc.Listing on record	Feb 14, 2023	Gift	-25,000	—	n/a (No price was disclosed in the filing)		SEC
Insight Molecular Diagnostics Inc.Listing unverified	Dec 27, 2022	Buy	25,000	0.29 USD	$7.2K	conv 15	SEC
Insight Molecular Diagnostics Inc.Listing unverified	Aug 17, 2022	Buy	5,000	0.97 USD	$4.9K	conv 36ClusterFirst in 12mo	SEC
Insight Molecular Diagnostics Inc.Listing unverified	Aug 17, 2022	Award	10,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Insight Molecular Diagnostics Inc.Listing unverified	Aug 17, 2022	Buy	5,000	0.97 USD	$4.9K	conv 36ClusterFirst in 12mo	SEC
Insight Molecular Diagnostics Inc.Listing unverified	Aug 17, 2022	AwardD (derivative)	45,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Insight Molecular Diagnostics Inc.Listing unverified	Jul 19, 2022	ExerciseD (derivative)	-10,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Insight Molecular Diagnostics Inc.Listing unverified	Jul 19, 2022	Exercise	10,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Lineage Cell Therapeutics, Inc.Listing on record	Jul 6, 2022	AwardD (derivative)	50,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Lineage Cell Therapeutics, Inc.Listing on record	Feb 11, 2022	Gift	-14,700	—	n/a (No price was disclosed in the filing)		SEC
Lineage Cell Therapeutics, Inc.Listing on record	Jul 1, 2021	AwardD (derivative)	80,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Insight Molecular Diagnostics Inc.Listing unverified	Jun 28, 2021	AwardD (derivative)	45,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Insight Molecular Diagnostics Inc.Listing unverified	Jun 28, 2021	AwardD (derivative)	10,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Lineage Cell Therapeutics, Inc.Listing on record	Jun 23, 2021	Exercise	61,800	2.20 USD	$136K	Unusual size	SEC
Lineage Cell Therapeutics, Inc.Listing on record	Jun 23, 2021	ExerciseD (derivative)	-61,800	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Lineage Cell Therapeutics, Inc.Listing on record	Feb 12, 2021	Gift	-17,500	—	n/a (No price was disclosed in the filing)		SEC
Insight Molecular Diagnostics Inc.Listing unverified	Dec 28, 2020	Exercise	1,237	1.34 USD	$1.7K		SEC
Insight Molecular Diagnostics Inc.Listing unverified	Dec 28, 2020	ExerciseD (derivative)	65,271	1.34 USD	$87.5K		SEC
Insight Molecular Diagnostics Inc.Listing unverified	Dec 28, 2020	ExerciseD (derivative)	1,237	1.34 USD	$1.7K		SEC
Insight Molecular Diagnostics Inc.Listing unverified	Dec 28, 2020	Sell	-900	2.55 USD	$2.3K		SEC
Insight Molecular Diagnostics Inc.Listing unverified	Dec 28, 2020	Exercise	65,271	1.34 USD	$87.5K		SEC